CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 144 Insider Sale of Securities
- 4 Planned sale CLO & Secretary sold 5,000 shares at an average $286.09 ($1,430,434)
- 144 Insider Sale of Securities
- 8-K/A Event Exhibits
- 4 Planned sale Chief Financial Officer sold 31,641 shares at $292.07 ($9,241,229)
- 4 Open-market sale Director sold 7,138 shares at $292.81 ($2,090,062)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale CLO & Secretary sold 5,000 shares at an average $288.99 ($1,444,951)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Regulation FD disclosure
- 4 Planned sale CLO & Secretary sold 5,000 shares at an average $313.28 ($1,566,377)
- 4 Other acquisition Chief Financial Officer acquired 17 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 132 shares (other)
- 144 Insider Sale of Securities
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Material agreement · Other events
Page 2 of 115 · 2,299 filings